Compare FMC Corp (FMC) vs iShares Russell 2000 ETF (IWM) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

IWM trades at $295.49, up 0.35% today, with technical indicators showing a bullish trend from moving averages while oscillators remain neutral. The ETF has gained significant attention for outperforming large-cap benchmarks year-to-date, driven by renewed investor interest in small-cap stocks amid shifting interest rate expectations. Recent news highlights strong flows into small-cap ETFs, though some analysts caution about valuation traps and moderating growth.

Outlook remains positive given small-caps' historical performance during economic expansions, but risks include higher volatility, sensitivity to interest rates, and concentration concerns. The ETF's expense ratio of 0.19% is competitive, though slightly higher than some alternatives. Continued outperformance hinges on sustained economic growth and favorable monetary policy.